PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 208 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,156 | -19.2% | 11,185 | +5.6% | 0.00% | -50.0% |
| Q2 2023 | $424,542 | -52.5% | 10,595 | -51.7% | 0.00% | 0.0% |
| Q1 2023 | $894,474 | +45.8% | 21,918 | +38.0% | 0.00% | +100.0% |
| Q4 2022 | $613,320 | -50.8% | 15,885 | -32.2% | 0.00% | -66.7% |
| Q3 2022 | $1,247,000 | +7.8% | 23,439 | +18.1% | 0.00% | 0.0% |
| Q2 2022 | $1,157,000 | -38.2% | 19,844 | -19.2% | 0.00% | -25.0% |
| Q1 2022 | $1,873,000 | -21.0% | 24,547 | -37.7% | 0.00% | -20.0% |
| Q4 2021 | $2,371,000 | +21.6% | 39,401 | +13.2% | 0.01% | 0.0% |
| Q3 2021 | $1,950,000 | -7.3% | 34,817 | +0.4% | 0.01% | 0.0% |
| Q2 2021 | $2,104,000 | +61.6% | 34,668 | +86.7% | 0.01% | +25.0% |
| Q1 2021 | $1,302,000 | -36.6% | 18,571 | -45.9% | 0.00% | -42.9% |
| Q4 2020 | $2,055,000 | +97.8% | 34,347 | +98.8% | 0.01% | +75.0% |
| Q3 2020 | $1,039,000 | +33.5% | 17,275 | +16.5% | 0.00% | 0.0% |
| Q2 2020 | $778,000 | +156.8% | 14,832 | +64.2% | 0.00% | +100.0% |
| Q1 2020 | $303,000 | -13.7% | 9,031 | +16.6% | 0.00% | 0.0% |
| Q4 2019 | $351,000 | +10.4% | 7,742 | -7.4% | 0.00% | 0.0% |
| Q3 2019 | $318,000 | +23.7% | 8,357 | +41.2% | 0.00% | +100.0% |
| Q2 2019 | $257,000 | -3.7% | 5,919 | -15.6% | 0.00% | 0.0% |
| Q1 2019 | $267,000 | -17.1% | 7,013 | -6.2% | 0.00% | -50.0% |
| Q4 2018 | $322,000 | +24.8% | 7,480 | +42.6% | 0.00% | +100.0% |
| Q3 2018 | $258,000 | +28.4% | 5,244 | +19.3% | 0.00% | 0.0% |
| Q4 2017 | $201,000 | -11.5% | 4,394 | +71.6% | 0.00% | -66.7% |
| Q1 2015 | $227,000 | 0.0% | 2,560 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $227,000 | -8.5% | 2,560 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $248,000 | +5.5% | 2,560 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $235,000 | – | 2,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |